Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Issues Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Northland Capital Markets Downgrades Edwards Lifesciences (EW) to Market Perform
April 25, 2018 8:12 AM EDTNorthland Capital Markets downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Market Perform with a price target of $120.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $134.67 yesterday.
... MoreEdwards Lifesciences (EW) PT Lowered to $145 at Evercore ISI
April 25, 2018 6:40 AM EDTEvercore ISI lowered its price target on Edwards Lifesciences (NYSE: EW) to $145.00 (from $151.00) while maintaining an Outperform rating following results.
... More


